San Francisco, 30 January 2019: The
Report Transplant Diagnostics Market Size, Share & Trends Analysis Report By Technology
(Molecular Assays, Non-Molecular Assays), By Product (Reagents &
Consumables, Instruments), And Segment Forecasts, 2018 - 2024
The global transplant diagnostics market size is expected to reach USD 895.2 million by 2024,
according to a new report by Grand View Research, Inc. It is projected to
expand at a CAGR of 7.6% over the forecast period. Increasing number of
patients suffering from chronic diseases frequently leading to organ failure is
creating an upsurge in demand for transplant procedures. In addition, adoption
of stem cell therapy and personalized medicine is escalating, thereby
influencing demand for transplant diagnostics.
Risks and complexities associated with
organ transplants necessitate the need for improved and sophisticated
diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly
replacing traditional diagnostic methods, such as serological techniques
employed in Human Leukocyte Antigen (HLA) typing, owing to growing demand for
high-throughput diagnostic tools with enhanced accuracy.
Market growth is expected to be restrained
by factors such as reimbursement controversies and ethical issues in some parts
of the world. In addition, high cost of performing HLA matching using
Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of
the transplant diagnostics market in developing countries.
Access Research Report of Transplant
Diagnostics Market @ www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market
Further key findings from the study suggest:
· PCR-based molecular assay captured the
largest share in the overall market in 2016 due to extensive adoption in HLA
typing
· The sequencing-based typing segment is
anticipated to witness significant growth from 2016 to 2024. High adoption of
NGS is a major factor driving segment growth
· In 2016, the reagents and consumables
segment accounted for the largest market share attributed to repeat purchase
· North America captured the largest revenue
share in 2016 and is expected to maintain its dominance throughout the forecast
period due to well-established research infrastructure, increasing healthcare
expenditure, high adoption of advanced diagnostic techniques, and growing
R&D activities
· Asia Pacific is expected to witness
significant growth during the forecast period owing to expanding research
opportunities, healthcare expenditure, medical tourism industry, and awareness
regarding organ donation
· Some major players in this market are
Thermo Fisher Scientific, Inc.; Illumina, Inc.; F.Hoffmann La-Roche AG.; Abbott
Laboratories, Inc.; Qiagen N.V.; Immucor Transplant Diagnostics, Inc.; Bio-Rad
Laboratories, Inc.; Affymetrix, Inc.; and Omixon Ltd.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global transplant
diagnostics market on the basis of technology, product, and region:
Transplant Diagnostics Technology Type
Outlook (Revenue, USD Million, 2014 - 2024)
·
Molecular Assay
·
Non-molecular Assay
Transplant Diagnostics Product Type Outlook (Revenue, USD
Million, 2014 - 2024)
·
Reagents & Consumables
·
Instruments
·
Software and Services
Transplant Diagnostics Regional Outlook
(Revenue, USD Million, 2014 - 2024)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Access Press Release of
Transplant Diagnostics Market@ www.grandviewresearch.com/press-release/global-transplant-diagnostic-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business decisions,
we offer market intelligence studies ensuring relevant and fact-based research
across a range of industries, from technology to chemicals, materials and
healthcare.
No comments:
Post a Comment